

Asimov Press
Asimov Press
Audio recordings of Asimov Press essays and science fiction, focused on the science and technologies that promote a flourishing future.
Episodes
Mentioned books

Mar 30, 2025 • 43min
The Nobel Duel
A cautionary tale about the competitive pressures of scientific research, and how they alter the course of history. Written by Metacelsus and recorded by Xander Balwit.Read every article from Asimov Press by visiting www.asimov.press.

Mar 30, 2025 • 24min
The Nobel Duel [Interview]
A behind-the-scenes discussion with Metacelsus, author of "The Nobel Duel," a cautionary tale about the competitive pressures of scientific research and how they alter the course of history.Read every article from Asimov Press by visiting www.asimov.press.

9 snips
Mar 26, 2025 • 7min
What Limits a Cell’s Size?
Explore the fascinating reasons behind why cells are so small, focusing on the crucial role of surface area-to-volume ratios and diffusion. Discover how cell size and shape have evolved for optimal performance, with intriguing examples like donut-shaped red blood cells that boost oxygen exchange. Delve into the world of cell compartmentalization and meet a giant bacterium that defies traditional expectations of cell size, showcasing nature's innovative adaptations.

Mar 23, 2025 • 24min
A Brief History of the Miracle Bacterium
Serratia marcescens’ vivid blood-red color has prompted its use in a wide range of experiments that have increased our understanding of how germs disperse within human bodies, buildings, and populations. Sightings of the striking microbe outside the lab have awakened both fear and awe in the general population. The awareness that certain strains of Serratia marcescens can cause severe harm to humans — counter-intuitively, the paler varieties are most dangerous — only became evident decades after Gordon’s investigations. Before then, hospitals deliberately sprayed Serratia marcescens inside their facilities to investigate microbial dispersion, and laboratory handbooks demonstrated transmission by handshake by having students coat their fingers in the microbe. While greater awareness of its dangers eventually led to its discontinuation in tracing experiments, Serratia marcescens remains an important subject of biomedical research. Its scientific journey began over 200 years ago with a bloody polenta.Read every article from Asimov Press, for free, by visiting press.asimov.com.

Mar 23, 2025 • 21min
A Brief History of the Miracle Bacterium [Interview]
Serratia marcescens, a pathogen with an uncanny resemblance to blood, has had an outsized influence on modern science. In the latest article from Asimov Press, author Corrado Nai explains how research into this organism has revealed how handshakes transmit disease, how bacteria enter the bloodstream, and how an illness can spread through large cities. Our audio correspondent, Carlos Bricio, interviewed Corrado Nai to learn more.You can read every article from Asimov Press, for free, by visiting press.asimov.com.

Mar 19, 2025 • 22min
Meet the Humans Building AI Scientists
A look inside FutureHouse, a nonprofit research institute in San Francisco.Read every article from Asimov Press, for free, at press.asimov.com.

Mar 18, 2025 • 19min
Driving Toward Nanopores
A nanopore sequencer is a tiny device that can read DNA with high accuracy. Its invention, made possible by merging hardware with machine learning, holds lessons for other measurement tools. By Stephen Malina.Read all articles from Asimov Press, for free, at press.asimov.com.

Mar 16, 2025 • 30min
Healing My Family’s Future
How genetics and IVF empowered one researcher's family to leave cancer behind. Read every article from Asimov Press, for free, by visiting press.asimov.com.

Mar 14, 2025 • 19min
Measuring the Black Death
Reports suggest that between 40 and 60 percent of the population died during the bubonic plague that swept through Europe in the mid-1300s. What accounts for this wide range of estimates?

Feb 23, 2025 • 23min
Making a “Miracle” HIV Medicine
In 2024, the pharmaceutical company Gilead announced that a single injection of lenacapavir protected 96 to 100 percent of recipients from HIV for up to six months. This article explains how they made it, how much it costs, and how we can help ensure it reaches those who need it most.Read every article from Asimov Press at press.asimov.com.


